Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Balance Sheet

Compare
445 Followers

Spyre Therapeutics Balance Sheet

Spyre Therapeutics's total assets for Q4 2024 were $608.48M, an increase of 44.50% from the previous quarter. SYRE total liabilities were $90.68M for the fiscal quarter, a -3.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 608.48M$ 341.86M$ 71.14M$ 109.93M$ 161.62M
Total Liabilities
$ 90.68M$ 157.84M$ 20.84M$ 25.98M$ 21.79M
Total Equity Gross Minority
$ 517.80M$ 184.02M$ 50.30M$ 83.94M$ 139.83M
Other Metrics
Currency in USD

Spyre Therapeutics Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis